Dr Reddys lab is reporting significant improvement in the US business? What are your views on this?
It is also one of the companies which has weathered the market meltdown and is quoting a healthy Rs. 1180 today, far higher than the pre-market meltdown price that existed in December 2007.
With U.S sales going to show significant improvement, bottomline too is going to show a healthy state unlike FY ending 2009 when it reported a loss. The first half has been so far good and in terms of a recommendation to buy, it will worth taking this in the portfolio at a level around Rs. 1000 for those who dont want to take a risk at this level. It is a laggard in the market and had been shifted from Nifty to Nifty Junior last year due t ...more